Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzeň

Thrombosis and Haemostasis

Volumn 102, Issue 3, 2009, Pages 479-486

  Kotlín, Roman ^a   Reicheltová, Zuzana ^a   Malý, Martin ^b   Suttnar, Jiří ^a   Sobotková, Alžběta ^a   Salaj, Peter ^a   Hirmerová, Jana ^c   Riedel, Tomáš ^a,d   Dyr, Jan E ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

Author keywords

Dysfibrinogenemia; Fibrinogen; Missense mutation; Pulmonary embolism; Thrombosis

Indexed keywords

ASPARAGINE; FIBRINOGEN; FIBRINOPEPTIDE; GENOMIC DNA; TYROSINE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING TEST; CASE REPORT; DNA DETERMINATION; DNA SEQUENCE; DYSFIBRINOGENEMIA; FEMALE; FGA GENE; FGB GENE; FGG GENE; FIBRIN POLYMERIZATION; FIBRINOLYSIS; GENE; GENE MUTATION; HUMAN; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE AGGREGATION; THROMBOSIS;

ADULT; BLOOD COAGULATION; COAGULATION PROTEIN DISORDERS; FEMALE; FIBRIN; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; MUTATION; PLATELET AGGREGATION; PULMONARY EMBOLISM; THROMBOSIS;

EID: 70449392424     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-11-0771     Document Type: Article

References (46)

1. UCSC Genome Browser. http://genome.ucsc.edu/cgi-bin/hgTracks?position= chr4:155100001-161500000&hgsid=106991619. Accessed 5. 11. 2008.
2. Medved L, Weisel JW. Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost 2009; 7: 355-359.
3. Pratt KP, et al. The primary fibrin polymerisation pocket: Three-dimensional structure of a 30-kDa C-terminal γ chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci USA 1997; 94: 7176-7181. (Pubitemid 27345288)
4. Hanss M, Biot F. A Database for Human Fibrinogen Variants. Ann NY Acad Sci 2001; 936: 89-90. Available at: http://www.geht.org/databaseang/fibrinogen, release 28.
5. Monaldini L, et al. Mutational screening of six afibrinogenemic patients: Identification and characterization of four novel molecular defects. Thromb Haemost 2007; 97: 546-551. (Pubitemid 46592931)
6. Brennan SO, et al. Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a γ320Asp deletion at the Ca2+ binding site. Thromb Haemost 2007; 98: 467-469.
7. Davis RL, Brennan SO. Fibrinogen Tolaga Bay: A novel γAla341Val mutation causing hypofibrinogenaemia. Thromb Haemost 2007; 98: 1136-1138.
8. Flood VH, et al. Fibrinogen Hershey IV: A novel dysfibrinogen with a γV411I mutation in the integrin αIIbβ3 binding site. Thromb Haemost 2008; 99: 1008-1012.
9. Kotlín R, et al. Three cases of abnormal fibrinogens: Šumperk (BβHis67Leu), Uničov (BβGly414Ser), and Brno (γArg275His). Thromb Haemost 2008; 100: 1199-1200.
10. Davis RL, et al. Fibrinogen Foxton: A novel BβA277V mutation causing low normal plasma fibrinogen concentration, Thromb Haemost 2008; 100: 708-710.
11. Okumura N, et al. Fibrinogen Matsumoto I: a gamma 364 Asp→His (GAT-->CAT) substitution associated with defective fibrin polymerization. Thromb Haemost 1996; 75: 887-891. (Pubitemid 26355342)
12. Yoshida N, et al. Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis. J Biol Chem 1992; 267: 2753-2759.
13. Brennan SO, et al. Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology 2002; 36: 652-658.
14. Francalanci P, et al. Severe liver disease in early childhood due to fibrinogen storage and de novo gamma375Arg→Trp gene mutation. J Pediatr 2006; 148: 396-398.
15. Rubbia-Brandt L, et al. Fibrinogen gamma375 Arg→Trp mutation (fibrinogen Aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reti culum storage disease and cirrhosis. Am J Surg Pathol 2006; 30: 906-911. (Pubitemid 44264984)
16. Bentolila S, et al. Association dysfibrinogénémie et thrombose. A propos d'un famille (Fibrinogène Melun) et revue de la littérature. Ann Med Interne 1995; 146: 575-580.
17. 330→Val) characterized by a defective fibrin polymerization site "a". Blood 2000; 96: 3473-3479.
18. Lefebvre P, et al. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk). Blood 2004; 103: 2571-2576. (Pubitemid 38393009)
19. Marchi RC, et al. A novel mutation (deletion of Aalpha- Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot. Blood Coagul Fibrinolysis 2004; 15: 559-567.
20. Brennan SO, et al. Aberrant hepatic processing causes removal of activation peptide and primary polymerization site from fibrinogen Canterbury (Aá Val→Asp). J Clin Invest 1995; 96: 2854-2858.
21. Kotlín R, et al. A novel fibrinogen variant - Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution. Eur J Haematol 2008; 81: 123-129. (Pubitemid 352019636)
22. Kotlín R, et al. Acquired dysfibrinogenemia secondary to multiple myeloma. Acta Haematol 2008; 120: 75-81.
23. Kotlín R, et al. A novel fibrinogen variant - Praha I: hypofibrinogenemia associated with γ351 Gly→Ser substitution. Eur J Haematol 2007; 78: 410-416. (Pubitemid 46558200)
24. Dyr JE, et al. Optical sensing of the initial stages in the growth and development of fibrin clot. Sens Actuators B Chem. 2001; 74: 69-73.
25. Dyr JE, et al. Fibrinopeptide-releasing enzymes in the venom from the southern copperhead snake (agkistrodon- contortrix-contortrix). Toxicon 1989; 2: 359-373.
26. Dyr JE, et al. Molecular arrangement of adsorbed fibrinogen molecules characterized by specific monoclonal antibodies and a surface plasmon resonance sensor. Sens Actuators B Chem 1998; 51: 268-272.
27. Suttnar J, et al. Determination of fibrinopeptides by high performance liquid chromatography. Biochem Clin Bohemoslov 1989; 18: 17-25. (Pubitemid 19069787)
28. Miller SA, et al. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16: 1215.
29. Vaníčková M, et al. The adhesion of blood platelets on fibrinogen surface: comparison of two biochemical microplate assays. Platelets 2006; 17: 470-476. (Pubitemid 44665570)
30. Kotlín R, et al. Fibrinogen Nový Jičín and Praha II: Cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Thromb Res 2007; 121: 75-84.
31. Kollman J, et al. Crystal structure of human fibrinogen. Biochemistry 2009; 48: 3877-3886.
32. Spraggon G, et al. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 1997; 389: 455-462. (Pubitemid 27435313)
33. Brown JH, et al. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci USA 2000; 97: 85-90.
34. Doolittle RF. Fibrinogen and fibrin. Sci Am 1981; 245: 92-101.
35. Okumura N, et al. A novel variant fibrinogen, deletion of Bbeta111Ser in coiled-coil region, affecting fibrin lateral aggregation. Clin Chim Acta. 2006; 365: 160-167. (Pubitemid 43196433)
36. Doolittle RF, et al. Designation of sequence involved in the coiled-coil interdomainal connections in fibrinogen: construction of an atomic scale model. J Mol Biol 1978; 120: 311-325.
37. Voskuilen, M, et al. Fibrinogen lysine residue A alpha 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator. J Biol Chem 1987; 262: 5944-5946.
38. Smith RA, et al. Evidence for new endothelial cell binding sites on fibrinogen. Thromb Haemost. 2000; 84: 819-825.
39. Farrell DH, et al. Role of fibrinogen αand γ chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89: 10729-10732.
40. Medved L, et al. Conformational changes upon conversion of fibrinogen into fibrin: the mechanisms of exposure of some cryptic sites. Ann NY Acad Sci 2001; 936: 185-204. (Pubitemid 32613904)
41. Marder VJ, Francis CW. Plasmin degradation of cross-linked fibrin. Ann NY Acad Sci 1983; 408: 397-406.
42. Neerman-Arbez M, et al. Mutations in the fibrinogenAa gene account for the majority of cases of congenital afibrinogenemia. Blood 2000; 96: 149-152. (Pubitemid 30456464)
43. Neerman-Arbez M, et al. The 11 kb FGA deletion responsible for congenital afibrinogenaemia is mediated by a short direct repeat in the fibrinogen gene cluster. Eur J Hum Genet 1999; 7: 897-902. (Pubitemid 30032296)
44. Marchi RC, et al. A novel mutation (deletion of Aα-Asn80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot. Blood Coagul Fibrinol 2004; 15: 559-567.
45. Yamazumi K, Doolittle RF. Photoaffinity labeling of the primary fibrin polymerization site: Localization of the label to γ-chain Tyr-363. Proc Natl Acad Sci USA 1992; 89: 2893-2896.
46. Doolittle RF, et al. Difference in binding specificity for the homologous γ-and β-chain "holes" on fibrinogen: Exclusive binding of Ala-His-Pro-amide by the β-chain hole. Biochemistry 2006; 45: 13962-13969.